E2 ModerateModerate confidencePEM requiredCross-SectionalPeer-reviewedMachine draft
Health outcomes one year after Omicron infection among 12,789 adults: a community-based cross-sectional study.
Zhang, Hui, Yang, Peng, Gu, Xiaoying et al. · The Lancet regional health. Western Pacific · 2025 · DOI
Quick Summary
This study followed over 12,000 people in Beijing who had COVID-19 (Omicron variant) about one year earlier. Researchers found that roughly 8% still had long COVID symptoms, with fatigue and post-exertional malaise (feeling worse after activity) being the most common complaints. People who had been reinfected with COVID were at much higher risk of developing long COVID.
Why It Matters
This large, well-characterized cohort provides robust epidemiological data on long COVID prevalence and phenotyping one year post-infection, including objective biomarkers (lung function, imaging) often absent from patient-reported surveys. The findings on post-exertional malaise, neurological symptom progression, and the dose-response relationship with reinfection have direct relevance for understanding ME/CFS-like presentations in post-viral populations.
Observed Findings
- 7.8% (995/12,789) of participants experienced long COVID one year post-Omicron infection, with 5.1% (651) having persistent symptoms.
- Fatigue was the most common symptom (60.1%), followed by post-exertional malaise (36.9%); brain fog had the poorest resolution rate at 4.2%.
- Reinfection significantly increased long COVID risk: one reinfection (OR 2.592, 95% CI 2.188–3.061) and two or more reinfections (OR 6.171, 95% CI 3.227–11.557).
- Participants with persistent long COVID had reduced muscle strength, lower exercise capacity, and poorer health-related quality of life compared to recovery controls.
- Abnormal lung function (FEV₁ <80% predicted: 13.0% vs. 2.0%) and radiographic abnormalities (23.5% vs. 13.6%) were significantly more common in the persistent long COVID group.
Inferred Conclusions
- Long COVID represents a substantial health burden one year post-Omicron infection, affecting ~8% of infected individuals, with persistent neurological symptoms (especially brain fog) showing minimal spontaneous resolution.
- Reinfection substantially amplifies the risk of long COVID, suggesting a dose-dependent or cumulative viral exposure effect.
- Persistent long COVID is associated with measurable physiological impairment across multiple organ systems (muscle, respiratory, neurological), supporting the need for standardized diagnostic criteria and objective biomarkers.
Remaining Questions
What This Study Does Not Prove
As a cross-sectional study, it cannot establish causality or temporal precedence of specific symptoms; it also cannot determine whether observed physiological abnormalities (reduced muscle strength, lung function) are directly caused by viral infection or mediated by deconditioning, behavioral changes, or other confounders. The study does not compare long COVID to pre-infection baseline health status, limiting ability to attribute findings solely to the infection.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionFatigue
Biomarker:NeuroimagingBlood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Strong PhenotypingSex-Stratified
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →